Regenerative Medicine Market in Japan 2016-2020

Regenerative Medicine Market in Japan 2016-2020

  • September 2016 •
  • 102 pages •
  • Report ID: 4213445 •
  • Format: PDF
About Regenerative Medicine

Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat damaged or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, gene therapy, and cell therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues, whereas cell therapy helps in treating the functioning of existing cells.

Technavio’s analysts forecast the regenerative medicine market in Japan to grow at a CAGR of 35.3% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the regenerative medicine market in Japan for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of regenerative medicine products to end-users like hospitals, ambulatory surgical centers (ASCs), and clinical research laboratories.

The market is divided into the following segments based on product:
- Tissue Scaffold
- Cell Therapy

Technavio's report, Regenerative Medicine Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- CellSeed
- JCR Pharmaceuticals
- Japan Tissue Engineering
- Terumo
- Astellas
- Caladrius Biosciences
- Healios
- Fujifilm
- Rohto Pharmaceuticals

Other prominent vendors
- FUJISOFT Tissue Engineering
- MediBIC
- Nikon
- Cyfuse Biomedical
- Irvine Scientific
- Kaken
- Regience
- Sumitomo Dainippon
- Takeda
- Alfresa
- MEDIPAL Holdings

Market driver
- Growing partnerships of MNCs with local vendors in Japan
- For a full, detailed list, view our report

Market challenge
- High cost and failure rate in clinical trials coupled with inadequate clinical evidence
- For a full, detailed list, view our report

Market trend
- Strong pipeline portfolio of regenerative medicines
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.